11 Oct 2018
ICYMI: Three big takeaways from Grand Challenges in Parkinson’s Disease
//
Comments0
/Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a...Read More
17 Apr 2018
Meet the scientist behind the science: Dr. Viviane Labrie
Dr. Viviane Labrie leads a lab in Van Andel Research Institute’s Center for Neurodegenerative Science. Her team studies the dynamic interplay between the human...Read More
27 Nov 2017
Can alpha-synuclein in the gut impact the brain?
Scientists have a gut feeling about Parkinson’s disease. Namely, that it may not start in the brain, the organ most often associated...Read More
7 Nov 2017
Stemming inflammation offers new hope for treating Parkinson’s disease
For the seven to 10 million people worldwide with Parkinson’s disease, a medication that actually slows down their disease and staves off...Read More
14 Jun 2016
Lessons from lactose intolerance: Investigating epigenomic aging
New insights into lactose intolerance may give scientists more than a better understanding of why some people lose the ability to digest...Read More
24 May 2016
Explaining the epigenome: An interview with Dr. Viviane Labrie (part two)
Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the...Read More
17 May 2016
Explaining the epigenome: An interview with Dr. Viviane Labrie (part one)
Dr. Viviane Labrie is an assistant professor in Van Andel Research Institute’s Center for Neurodegenerative Science. Her area of expertise is the...Read More